News

News Filters

NHIF: Supporting home infusion

The National Home Infusion Foundation (NHIF) invests in and performs research as well as recognizes and supports outstanding home infusion professionals and their work.
SITE: nhia
NHIA commented on CMS’s Information Collection Request (ICR) regarding the Medicare Transaction Facilitator (MTF) that will be used in facilitating negotiated prices under the Medicare Drug Price Negotiation program.
SITE: nhif
The National Home Infusion Foundation (NHIF) welcomes the 2025-2026 Board of Directors.
SITE: nhia
The National Home Infusion Association (NHIA) is pleased to announce that Greg LoPresti, CEO Upstate HomeCare has been named Chair of its Board of Directors. LoPresti will lead the trade association representing companies that provide medically necessary infusion therapies to patients in alternate sites, as well as companies that manufacture and supply infusion and specialty pharmacy products.
SITE: nhia
Last week concluded the 2025 National Home Infusion Association Annual Conference (NHIA 2025), which brings together 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits. This year’s event saw significant growth in individuals investing to attend the event and the expo featured 150 companies displaying the latest products and services supporting the industry.
SITE: nhif
The National Home Infusion Foundation (NHIF) is proud to announce that the recipient of the 2025 Outstanding Abstract Achievement Award (OAAA) is Leslie Myers, PharmD, IgCP of CSI Pharmacy.
SITE: nhia
The National Home Infusion Association has announced the finalists for its 2025 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
SITE: nhia
NHIA announces two new companies will join its 2024-2025 Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Joining the NHIA Board of Directors are Pentec Health, represented by Matthew Deans, CEO and Vital Care Infusion Services, represented by Logan Davis, Executive VP of Trade Relations and Strategy. In addition to the newly installed members, Upstate Home Care, Froedtert Health, and Amerita were elected to additional terms.
SITE: nhia
The National Home Infusion Association (NHIA) is proud to announce that Mitra Gavgani, PharmD is the recipient of the 2025 Gene Graves Lifetime Achievement Award.
SITE: nhia
The National Home Infusion Association (NHIA) applauds the re-introduction of The Preserving Patient Access to Home Infusion Act – bipartisan, bicameral legislation that will ensure Medicare patients can receive the intravenous (IV) medications they need while at home.
SITE: nhif
NHIF is proud to announce that Maritza DeGagne, RPh is the recipient of the 2025 Lynn Giglione Women in Leadership Award, which recognizes and honors trail-blazing and emerging women leaders who have demonstrated exemplary service to patients and their peers while promoting the mission of NHIF.
SITE: nhif
The National Home Infusion Association (NHIA) is pleased to announce the 2025 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals. The prestigious NHIA Fellow Program aims to advance the home and alternate site infusion profession by recognizing the contributions and achievements of highly accomplished individuals.
SITE: nhif
The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2025. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.
SITE: nhia
NHIA submitted comments to CMS on its Draft Medicare Transaction Facilitator (MTF) Agreements, which will be used to implement negotiated prices for drugs under the Medicare Drug Price Negotiation Program.
SITE: nhia
NHIA is accepting applications for members of the association’s Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Seats are only open to provider members and are assigned at the organization level.
SITE: nhia
The National Home Infusion Association (NHIA) expressed deep concern today regarding the recently proposed government funding bill, which includes major changes to the qualifying criteria for drugs under Medicare’s home infusion benefit but fails to address the underlying flaws that have plagued the program. Without fixing the structure of the benefit, Medicare beneficiaries in need of home infusions for treatment of a variety of medical conditions, including rare diseases, are unlikely to gain access to home-based care.

Rep. Debbie Dingell (D-MI) Promotes Home Infusion During Energy & Commerce Hearing

On Tuesday, September 19, 2023, the House Energy & Commerce Health Subcommittee held a legislative hearing, “Examining Policies to Improve Seniors’ Access to Innovative Drugs, Medical Devices, and Technology.” Home infusion was discussed at least 3 distinct times throughout the hearing, with a consensus that Medicare needs to improve beneficiary access to home infusion services.

Read More »

NHIA Comments on Proposed 2024 Home Health Rule

NHIA submitted comments to CMS on the proposed 2024 home health payment rule. CMS did not mention the HIT services benefit in its 2024 rulemaking, however, NHIA believes it is important to continue advocating on behalf of Medicare beneficiaries to improve access to home infusion services.

Read More »

Cost Savings: Home Versus Inpatient Infusion Therapy, A Review of the Literature

Home infusion is a site of care (SOC) option for patients requiring intravenous (IV) or subcutaneous (SC) medications for treatment of acute and chronic medical conditions. Patients and payors have become aware of the sizeable cost savings associated with home infusion when compared to other SOC. There is a need to gain an understanding of the amount of savings associated with home infusion when compared to other SOCs such as the hospital. The literature review objective is to provide a critical evaluation of the current evidence of the cost savings associated with home and outpatient infusion therapy when compared to inpatient therapy.

Read More »

CMS Releases Home Health Proposed Rule for CY 2024

On Friday June 30, 2023, CMS released proposed updates to the Medicare Home Health Prospective Payment System for CY 2024. The proposed home health rule does not address home infusion therapy (HIT) services other than to describe the potential interaction with the new Home IVIG Items and Service benefit, which replaces the IVIG demonstration starting on January 1, 2024. 

Read More »

FDA Issues Guidance for Decentralized Clinical Trials

NHIA applauds the guidance issued by FDA to allow for decentralized clinical trials, including in patients’ homes. NHIA believes that allowing decentralized clinical trials will improve the representation in trials. According to the FDA guidance, “remote clinical trial visits and clinical trial-related activities are important strategies to make trials more convenient and more accessible” and “sponsors should strive for diversity and inclusiveness in trial populations.”

Read More »

NHIA 2023 Draws Record Attendance, Focuses on Future of Health Care and Health Equity

Last week concluded the 2023 National Home Infusion Association (NHIA) Annual Conference, which brings together nearly 1,500 home and alternate site infusion professionals for four days of networking, education, and expo. This year’s event saw significant growth in attendance over prior years and the expo featured more than 125 companies displaying the latest products and services supporting the industry.

Read More »

NHIA 2023 Tuesday – Health Equity in Home Infusion

Eliminating the inequities in how people access and receive health care can go a long way toward improving health care delivery, outcomes, and population health, according to Christina Ritchey from Optum Infusion Pharmacy. Equity in health care means the state in which everyone has a fair and just opportunity to attain their highest level of health.

Read More »

NHIA 2023 Monday, March 27 Recap

Attendees gathered for a morning coffee break after an engaging breakfast symposium from IgNS on PANS/PANDAS in Children. The beautiful backdrop overlooking the Potomac played host to some excellent conversations among professionals as everyone fueled up for a jam-packed day of education.

Read More »

NHIA 2023 Session Highlight: Navigating Post-Pandemic Stress for You and Your Team

As we enter the third year since the global pandemic and a return to “normal,” you might expect that trauma and anxiety related to the crisis would be waning. In fact, the opposite is true, according to Alissa Putman, PhD with Johns Hopkins Community Physicians. In 2022, 65% of psychologists reported an increase in symptom severity, including stress, anxiety, and depression. All of which can affect health care’s most precious resource: its workers.

Read More »

NHIA 2023 Sunday, March 26 Recap

With record attendance and beautiful spring weather in D.C., we had a full first day of action at NHIA 2023, starting off early with our three preconference seminars: Executive, Sterile Compounding and Revenue Cycle, covering valuable information for professionals in a variety of roles.

Read More »

Home infusion of IV antibiotics keeps ultramarathoner on course

Serious infections can sideline the best of plans. That’s what happened to Jusup, a Montana-based YouTuber with the ambitious goal of running a 100-mile race through the Salmon River mountains of Idaho. “I had never even raced in a 5K,” he recalls, “but, I was progressing in my goal of running at least 2 miles every day for a year and thought it would be a good test.”

Read More »

Rep. Debbie Dingell (D-MI) Promotes Home Infusion During Energy & Commerce Hearing

On Tuesday, September 19, 2023, the House Energy & Commerce Health Subcommittee held a legislative hearing, “Examining Policies to Improve Seniors’ Access to Innovative Drugs, Medical Devices, and Technology.” Home infusion was discussed at least 3 distinct times throughout the hearing, with a consensus that Medicare needs to improve beneficiary access to home infusion services.

Read More »

NHIA Comments on Proposed 2024 Home Health Rule

NHIA submitted comments to CMS on the proposed 2024 home health payment rule. CMS did not mention the HIT services benefit in its 2024 rulemaking, however, NHIA believes it is important to continue advocating on behalf of Medicare beneficiaries to improve access to home infusion services.

Read More »

Cost Savings: Home Versus Inpatient Infusion Therapy, A Review of the Literature

Home infusion is a site of care (SOC) option for patients requiring intravenous (IV) or subcutaneous (SC) medications for treatment of acute and chronic medical conditions. Patients and payors have become aware of the sizeable cost savings associated with home infusion when compared to other SOC. There is a need to gain an understanding of the amount of savings associated with home infusion when compared to other SOCs such as the hospital. The literature review objective is to provide a critical evaluation of the current evidence of the cost savings associated with home and outpatient infusion therapy when compared to inpatient therapy.

Read More »

CMS Releases Home Health Proposed Rule for CY 2024

On Friday June 30, 2023, CMS released proposed updates to the Medicare Home Health Prospective Payment System for CY 2024. The proposed home health rule does not address home infusion therapy (HIT) services other than to describe the potential interaction with the new Home IVIG Items and Service benefit, which replaces the IVIG demonstration starting on January 1, 2024. 

Read More »

FDA Issues Guidance for Decentralized Clinical Trials

NHIA applauds the guidance issued by FDA to allow for decentralized clinical trials, including in patients’ homes. NHIA believes that allowing decentralized clinical trials will improve the representation in trials. According to the FDA guidance, “remote clinical trial visits and clinical trial-related activities are important strategies to make trials more convenient and more accessible” and “sponsors should strive for diversity and inclusiveness in trial populations.”

Read More »

NHIA 2023 Draws Record Attendance, Focuses on Future of Health Care and Health Equity

Last week concluded the 2023 National Home Infusion Association (NHIA) Annual Conference, which brings together nearly 1,500 home and alternate site infusion professionals for four days of networking, education, and expo. This year’s event saw significant growth in attendance over prior years and the expo featured more than 125 companies displaying the latest products and services supporting the industry.

Read More »